BMSD : 10.65048
BMSD : 10.65048
https://doi.org/10.65048/ijbmr
Search
About Us
Authors
Reviewers
Editorial Board
Contact Us

International Journal of Biological and Medical Research (IJBMR)

Review Article
Year : 2026  |  Volume : 17  |  Issue : 2  |  Page : 8507-8509 Full Version
Review on knowledge, attitude and practice among patients with topical steroid-dependent face.
Int J Biol Med Res. 2026; 17(2): 8507-8509  |  DOI: 10.65048/ijbmr.2026.17.2.8507.1034
Dr Pdiangty Giri Mawlong
Assistant Professor, Dept of Dermatology, GMC Haldwani
Correspondence Address :
Dr Pdiangty Giri Mawlong,
Assistant Professor, Government Medical college Haldwani,
Dermatology Venereology and Leprology Department,
Haldwani, Uttarakhand
E-mail: pdiangtygmawlong29@gmail.com
Received: January 29, 2026 Accepted: March 17, 2026 Published: April 5, 2026

Abstract
Topical corticosteroids (TCS) are widely prescribed in dermatology due to their potent anti-inflammatory and immunosuppressive effects. However, indiscriminate and prolonged use, especially on the face, has led to a growing public health problem known as topical steroid-dependent face (TSDF). TSDF is characterized by erythema, burning, acneiform eruptions, telangiectasia, rosacea-like dermatitis, and rebound flares following withdrawal. Poor patient knowledge, inappropriate attitudes, and unsafe practices play a central role in the development and persistence of this condition. This narrative review aims to synthesize available literature on knowledge, attitude and practice (KAP) related to topical corticosteroid use among patients with facial dermatoses, emphasizing the epidemiology, behavioural determinants, clinical consequences, and management challenges of TSDF. The review also highlights the urgent need for patient education, regulatory reforms, and multidisciplinary interventions to address this preventable iatrogenic condition.
Keywords
Topical corticosteroids, Steroid misuse, Steroid-dependent face, Knowledge attitude practice, Dermatology.

Introduction

Topical corticosteroids (TCS) represent one of the most commonly prescribed drug classes in dermatology, owing to their proven efficacy in a wide range of inflammatory and immune-mediated dermatoses such as eczema, psoriasis, contact dermatitis, lichen planus, and autoimmune blistering diseases. Since their introduction in the 1950s, topical steroids have revolutionized dermatological therapy and significantly improved patient outcomes [1].

Despite their therapeutic benefits, topical steroids are associated with a spectrum of adverse effects, particularly when used inappropriately or for prolonged durations. The face is especially susceptible to steroid-induced damage because of its thin epidermis, high pilosebaceous density, and rich vascular network. Prolonged facial application may result in acneiform eruptions, rosacea-like dermatitis, telangiectasia, skin atrophy, hypertrichosis, perioral dermatitis, pigmentary alterations, and psychological dependence [2].

The term Topical Steroid-Dependent Face (TSDF) or Topical Steroid-Damaged Face (TSDF) was introduced to describe a clinical entity characterized by cutaneous damage and dependence behaviour, where patients experience worsening of symptoms upon steroid withdrawal and feel compelled to continue use [3]. TSDF represents not only a dermatological disorder but also a behavioural and public health problem driven by poor patient awareness, sociocultural factors, and weak regulatory systems.

In many developing countries, including India, topical steroids are widely available over the counter, often marketed as cosmetic fairness creams or acne treatments. The combination of easy accessibility, misleading advertisements, and lack of dermatological supervision has led to rampant misuse and increasing burden of TSDF [4].

This narrative review aims to examine the existing literature on knowledge, attitude, and practice (KAP) related to topical steroid use among patients with facial dermatoses, and to explore how these factors contribute to the development and persistence of TSDF.

EPIDEMIOLOGY OF TOPICAL STEROID MISUSE

Multiple studies across Asia, Africa, and the Middle East have reported widespread misuse of topical steroids, particularly on the face. In a multicentric prospective study conducted across India involving more than 2900 dermatology outpatients, Saraswat et al. reported that nearly 36% of patients had used topical steroids on the face, most without proper medical supervision [5].

Another study by Verma et al. found that approximately 50% of patients attending dermatology clinics had a history of topical steroid use, with a substantial proportion using these agents for non-medical cosmetic purposes such as fairness and acne treatment [6].

Young adults aged 18–35 years constitute the most affected demographic group, with a female predominance. This trend is likely influenced by sociocultural emphasis on facial appearance, peer pressure, and cosmetic marketing [7].

In rural and semi-urban settings, pharmacists and non-qualified practitioners often serve as primary healthcare providers, frequently dispensing potent steroids without prescriptions in addition to patients demand for cheap and rapid relief without addressing the side effects on the long run. This further exacerbates the problem and contributes to delayed diagnosis and management [8].

KNOWLEDGE AMONG PATIENTS

Awareness of Indications and Risks

Most KAP studies consistently demonstrate poor patient knowledge regarding the appropriate use of topical steroids. In a cross-sectional study conducted in Raipur, India, Rathod et al. found that more than 70% of patients were unaware of the correct indications and adverse effects of topical steroids [9].

Many patients believe that:

  • Topical steroids are harmless cosmetic creams
  • They can be used for any facial problem
  • Long-term use is safe
  • Stronger creams produce faster results

Only a minority of patients are aware of adverse effects such as skin thinning, steroid acne, pigmentation, and rebound flares [10].

Source of Information

Common sources of information include:

  • Pharmacists
  • Friends and family
  • Social media
  • Beauty advertisements
  • Previous prescriptions reused without follow-up

Dermatologists account for a surprisingly small proportion of information providers, indicating a major gap in professional guidance [11].

ATTITUDE OF PATIENTS

Patient attitudes play a critical role in the misuse of topical steroids. Several studies report that patients have a positive attitude toward immediate cosmetic results, often prioritizing short-term improvement over long-term safety [12].

Common attitudes include:

  • Overconfidence in self-medication
  • Belief that “if it worked before, it will work again”
  • Low perception of harm
  • Fear of withdrawal due to rebound flares

Even patients who are partially aware of adverse effects often continue misuse due to psychological dependence and cosmetic concerns [13].

PRACTICE PATTERNS

Common Usage Practices:

The most frequently reported unsafe practices include:

  • Self-prescription
  • Use without dermatological consultation
  • Prolonged continuous application
  • Sharing creams with others
  • Use of leftover prescriptions
  • Use of fixed-dose combinations

Fixed-dose combinations containing steroids, antifungals, and antibiotics are particularly problematic, as they promote inappropriate usage and mask underlying conditions [14].

Frequently Misused Agents: Commonly misused topical steroids include:Betamethasone, Mometasone, Clobetasol and Fluocinolone.

Popular brand combinations such as Panderm, Quadriderm, Skinlite, and Betnovate-N are widely abused [15].

Clinical Features of TSDF

TSDF is characterized by a constellation of symptoms and signs, including:Persistent facial erythema, burning and stinging sensation, acneiform eruptions, telangiectasia, rosacea-like dermatitis, hypertrichosis, skin atrophy and rebound flares on withdrawal.

Patients often report psychological distress, low self-esteem, anxiety, and compulsive behaviour related to steroid use [16].

Pathophysiology of Steroid Dependence

The pathogenesis of TSDF involves vasoconstriction followed by rebound vasodilation, epidermal barrier disruption, altered immune response and suppression of cutaneous corticosteroid receptors. Repeated exposure leads to tolerance, requiring higher potency or more frequent application to achieve the same effect, reinforcing dependence behaviour [17].

Management Challenges

Management of TSDF is complex and requires gradual tapering of steroids along with the use of non-steroidal anti-inflammatory agents in addition to psychological counselling and patient education.Withdrawal is often associated with severe rebound symptoms, making patient compliance difficult. Many patients relapse due to fear of worsening appearance [18].

PUBLIC HEALTH IMPLICATIONS

TSDF represents a preventable iatrogenic epidemic. The rising burden places significant strain on dermatology services and reflects systemic failures in drug regulation, healthcare access, and patient education. With the prolong usage of topical steroid, side effects persist for a long duration even after withdrawal of the drugs, thus significantly affects the patient quality of life as most of these side effects mainly affects the face.Effective strategies are therefore required which include restricting OTC steroid sales as well as training pharmacists with public awareness campaigns and incorporating KAP education into routine dermatology care [19]

FUTURE DIRECTIONS

Future research should focus on large-scale KAP surveys with behavioural intervention studies as well as using digital education tools and policy evaluation studies. Integrating behavioural science into dermatology practice is essential to address steroid misuse sustainably [20].

Conclusions

Topical steroid-dependent face is a growing dermatological and public health problem driven primarily by poor patient knowledge, inappropriate attitudes, and unsafe practices. Despite being preventable, TSDF continues to rise due to weak regulatory frameworks and widespread self-medication. Strengthening patient education, enforcing prescription regulations, and promoting responsible prescribing are essential to curb this epidemic.

Funding:

This paper did not receive any external funding. The co-authors independently financed the data collection and the preparation of this manuscript.




Conflicts of Interest:

The authors affirm that there are no conflicts of interest associated with the publication of this paper.


References

[1].Wolverton SE. Comprehensive Dermatologic Drug Therapy. 3rd ed. Elsevier; 2012.
[2].Coondoo A, Phiske M, Verma S, Lahiri K. Side-effects of topical steroids: A long overdue revisit. Indian Dermatol Online J. 2014;5(4):416–425.
[3].Lahiri K, Coondoo A. Topical steroid damaged/dependent face. Indian J Dermatol. 2016;61(3):265–272.
[4].Verma SB. Misuse of topical steroids: A social malpractice. Indian J Dermatol. 2014;59(5):448–450.
[5].Saraswat A, Lahiri K, Chatterjee M, et al. Topical corticosteroid abuse on the face: A prospective multicenter study. Indian J Dermatol VenereolLeprol. 2011;77(2):160–166.
[6].Verma SB, Madhu R. The great Indian epidemic of steroid misuse. Indian J Dermatol. 2017;62(4):454–455.
[7].Coondoo A. Topical corticosteroid misuse: The Indian scenario. Indian J Dermatol. 2014;59(5):451–455.
[8].Hajar T, Leshem YA, Hanifin JM, et al. A systematic review of topical steroid addiction. J Am Acad Dermatol. 2015;72(3):541–549.
[9].Rathod SP, et al. Knowledge, attitude and practice regarding topical steroids among dermatology outpatients. Indian J Dermatol VenereolLeprol. 2017.
[10].Dey VK. Misuse of topical corticosteroids: A clinical study of adverse effects. Indian Dermatol Online J. 2014;5(4):436–440.
[11].Sheth PB, Shah HA, Dave JN. Evaluation of topical corticosteroid use in dermatology OPD. Natl J Physiol Pharm Pharmacol. 2016.
[12].Hameed AF. Steroid dermatitis resembling rosacea. J Am Acad Dermatol. 2003;48(2):271–274.
[13].Rapaport MJ, Rapaport V. The red skin syndrome. Br J Dermatol. 2004;150(2):359–362.
[14].Panda S, et al. Fixed drug combinations in dermatology. Indian J Dermatol. 2015;60(5):484–489.
[15].Bhat YJ, et al. Steroid-induced rosacea-like dermatitis. Indian J Dermatol. 2011.
[16].Coondoo A, et al. Adverse effects of topical steroids. Indian J Dermatol. 2014.
[17].Hengge UR, et al. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1–15.
[18].Fukaya M, et al. Topical steroid addiction. J Dermatol. 2014.
[19].World Health Organization. Rational use of medicines. WHO; 2010.
[20].Chatterjee M, et al. Behavioral aspects of steroid misuse. Indian J Dermatol. 2018.


IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications